Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
23.25
-0.22 (-0.94%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Vera Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
112
Market Cap
1.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionVERA News
- 16 days ago - Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN - GlobeNewsWire
- 2 months ago - Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Top 3 Health Care Stocks That Could Blast Off This Quarter - Benzinga
- 3 months ago - Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 months ago - Vera Therapeutics to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock - GlobeNewsWire